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Abstract: This study aims to explore computed tomography (CT) and magnetic resonance imaging
(MRI) features of patients diagnosed with primary cardiac angiosarcoma. The study involved the
analysis of 12 patients diagnosed with primary cardiac angiosarcoma who underwent non-contrast
(8/12) or contrast-enhanced CT (10/12) or MRI (4/12). Imaging appearances, including the tumor
location and adjacent infiltration, were analyzed. All 12 lesions were located in the right atrium with
a broad base. Adjacent invasion including the tricuspid valve and right ventricle (2/12), inferior
or superior vena cava (2/12), pericardium (10/12), and right coronary artery (7/12) was common.
On unenhanced CT scans, tumors in two patients were homogeneous in density, whereas the others
were inhomogeneous. Ten patients showed heterogeneous enhancement. The enhancement pattern
showed no direct correlation with the differentiation degree of the tumor. Four lesions manifested
as heterogeneous intensity, with hyperintense hemorrhage foci on both T1- and T2-weighted MRI.
Three showed rim enhancement and one showed patchy enhancement. Primary cardiac angiosarcoma
often involves the right side of the heart with infiltration of peripheral structures. CT features include
typical inhomogeneous density on unenhanced scans and heterogeneous centripetal enhancement
on enhanced scans. A cauliflower-like appearance on both T1- and T2-weighted MRI is common.
The characteristic enhancement pattern of MRI remains to be determined.
Keywords: heart; angiosarcoma; computed tomography; magnetic resonance imaging
1. Introduction
Soft tissue sarcoma is a rare malignancy originating from mesenchymal cells, with a prevalence
of <1% of all adult cancers [1]. Primary cardiac sarcoma, which is an extremely rare subtype of soft
tissue sarcoma, has an incidence at autopsy of approximately 0.001–0.03% and a general incidence of
0.007% [2]. Primary cardiac angiosarcoma is the most common subset, accounting for approximately
30% of those cases [3]. Primary cardiac angiosarcoma predominantly occurs in men with a male/female
ratio of 2–3/1 [4], and it may occur at any age and anywhere in the heart; however, people aged between
30 and 50 years, and the right atrium, are the most frequently affected [5]. Clinical manifestations of
primary cardiac angiosarcomas are not specific and depend on their infiltration into the myocardium
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and adjacent structures as well as the extent of metastases [6]. Patients usually visit a hospital
for treatment because of their complications including chest pain, arrhythmia, peripheral edema,
dyspnea, orthopnea, congestive heart failure, and pericardial tamponade [7]. The prognosis of primary
cardiac angiosarcoma is considerably poor owing to many reasons including late diagnosis, extensive
metastases, incomplete resection, unsatisfactory effect of adjuvant therapy, and lack of standard
treatment. According to recent case series [8–11], the median overall survival ranges from several days
to several months. The diagnosis is challenging and usually remains exclusive. The use of noninvasive
imaging modalities for a comprehensive analysis of tumor features can improve the early detection
of cardiac neoplasms and may provide a specific classification before histopathological analysis [6].
However, the imaging characteristics of primary cardiac angiosarcoma are not well understood because
most of the current knowledge is mainly based on case reports. Therefore, we collected the clinical,
computed tomography (CT), and magnetic resonance imaging (MRI) data of 12 cases and analyzed the
imaging characteristics of primary cardiac angiosarcoma to improve understanding of the imaging
features of this particular disease, hence achieving the goal of earlier diagnosis and better prognosis.
2. Methods
2.1. Clinical Data
This retrospective study reviewed and analyzed 12 cases of pathologically confirmed primary
cardiac angiosarcoma from June 2009 to November 2019. Of these patients, 8 were from our hospital
(Beijing Anzhen Hospital, Capital Medical University) and the remaining 4 were from different medical
institutions (including Shanghai Dongfang Hospital, Shengjing Hospital of China Medical University,
Cangzhou Capital Hospital and Henan Provincial Chest Hospital). This study was approved by the
hospital Ethics Committee who waived the requirement for written informed consent because patients’
details were anonymous.
In total, there were 10 men and 2 women, with an average age of approximately 45 ± 18
(range: 17–74) years. The median time from onset to treatment was 1 (range: 0.5–12) month. Clinical
manifestations were not specific; the most common complaints included exertional dyspnea, palpitation,
and chest pain or hemoptysis. Two patients had a history of tuberculosis, and none of them had
familial or other specific histories. Laboratory test results showed an elevated serum carbohydrate
antigen-125 (CA-125) level in three patients, of whom two were men.
2.2. Imaging Data
Unenhanced and/or contrast-enhanced CT images were available for all the patients; however,
MRI data were available only for four patients.
The CT images were acquired using different scanners including 2 × 128-slice CT
(Somatom Definition Flash, Siemens Healthcare, Forchheim, Germany), 256-slice CT (Revolution CT,
GE Healthcare, Milwaukee, WI, USA), and 320-slice CT (Aquilion One, Toshiba, Otawara, Japan). The
tube voltage was 100 or 120 kV as automatically determined by the kV assist; the tube current was
set 300 mA with dynamic current modulation; matrix size was 512 × 512, collimation was 256 × 0.6/
0.625 mm or 320 × 0.5 mm, and reconstruction slice thickness was 1 mm. All the patients who
underwent enhanced CT examination were intravenously injected with a contrast agent (370 mg of
iodine/mL, Ultravist, Bayer Schering Pharma, Berlin, Germany) and 30 mL saline solution with a scan
delay of approximately 25 s for the arterial phase and 60 s for the venous phase after the onset of
injection. The flow volume was 50–60 mL, and the flow rate was 3.0 mL/s.
The MRI images were obtained using 3.0 T (Magnetom Verio, Siemens, Erlangen, Germany) and
3.0 T (Discovery MR750w, GE healthcare). Heart coils were used. All the patients were scanned using
routine protocols. T1- and T2-weighted black blood images were acquired in the axial plane, followed
by fat-suppressed images. Short axis, 2-chamber, 4-chamber, and left ventricular outflow tract cines
were obtained for the functional assessment. Short axis and/or axial rest perfusion stacks through the
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center of the mass were obtained using gadopentetate di-meglumine (Gd-DTPA). After approximately
10 min, late-phase gadolinium enhancement (LGE) images in short axis, 2-chamber, and 4-chamber
planes through the center of the mass were acquired. Gd-DTPA was injected at a rate of 1 mL/s, with a
dose of 0.1 mmol/kg for LGE.
PET-CT (Siemens Biograph 16, Siemens Medical Solutions) examination was performed in
4 patients.
2.3. Image Analysis
All the imaging data were evaluated by three specialists who had more than 15 years of experience
in diagnostic imaging of the cardiovascular system. Tumor features analyzed were as follows: location,
shape, maximum size, density/intensity, margin, infiltration, and enhancement pattern.
2.4. Pathological Analysis
The samples of all the patients were conventionally embedded, fixed, and stained with hematoxylin
and eosin and typed through immunohistochemistry. Three experienced pathologists majoring in
cardiovascular diagnosis read the results.
3. Results
3.1. General Results and Follow-Up
Clinical and imaging characteristics are listed in Table 1. Overall, six patients underwent radical
surgical operation and were discharged with stable condition; two died six and seven months,
respectively, after resection; one is still alive (with a survival of more than 15 months); and three
were lost to follow-up. In two patients who underwent thoracotomy, it was found that the lesion had
infiltrated too extensively to be completely excised, and biopsy specimens were cut off before closure.
One of them had aggressive progression and had a relapse approximately one month later. The other
patient received chemotherapy and is still alive (with a survival of approximately seven months).
Table 1. Clinical and imaging features of primary cardiac angiosarcomas.
Case Age a Sex Serum CA-125(U/mL) Attachment
Maximum
Size (mm) b
Adjacent
Invasion c Metastases Treatment
Surviving
(mo)
1 23 F Not Known Lateral wall 80.0 APRCA None Surgery 6(DOD)
2 74 M Normal Lateral wall 51.4
AP
RCA
RV
Lung
Lymph nodes Surgery 7(DOOD)
3 47 F 37.9 Lateral wall 93.0 Limited None Surgery 15(AFOD)
4 34 M Not Known Lateral wall 66.1 RCA None Surgery Not Known
5 50 M Not Known Lateral wall 69.7 AP None Surgery Not Known
6 62 M 99.0 Lateral wall 66.4 APRCA Pericardium Lung Surgery Not Known
7 61 M Not Known Atrialseptum 54.4
AP
SVC Lung Thoracotomy 1(DOD)
8 17 M Not Known Lateral wall 47.4 AP Lung Thoracotomy,Chemotherapy 7(AWD)
9 26 M Normal Lateral wall 79.5
AP
RCA
RV
Lung Chemotherapy 9(AWD)
10 61 M Not Known Lateral wall 38.4 APRCA Lung Chemotherapy 6(DOD)
11 31 M Not Known Lateral wall 81.2 APRCA
Pericardium Lung
Lymph nodes None 3(AWD)
12 52 M 1339.0 Posteriorwall 50.0
AP
IVC
Pericardium
Lung
Brain
Kidney
Spleen
None 3(AWD)
Abbreviations: F-female; M-male; AP-adjacent pericardium; RCA-right coronary artery; RV-right ventricular;
IVC-inferior vena cava; SVC-superior vena cava; DOD-died of disease; DOOD-died of other disease; AFOD-alive
free of disease; AWD-alive with disease. a Mean, 45 ± 18 years. b Mean, 64.8 ± 16.6 mm. c Limited adjacent invasion
indicates that the tumor is restricted to the right atrium without adjacent invasion.
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Of the four patients who could not undergo surgical treatment because of extensive metastases,
two received chemotherapy, medication such as cisplatin, cyclophosphamide, paclitaxel, and vincristine
was applied, one died six months after treatment, and the remaining patient is still alive (with a
survival of more than nine months). Two patients were discharged without any specific treatment
owing to a variety of reasons; they are still alive and undergo regular follow-ups.
3.2. Imaging Findings
All tumors were located in the right atrium with a broad base, 11 were adhered to the free wall
(10 to the lateral wall and 1 to the posterior wall), and one was attached to the atrial septum, wherein
the right atrium was significantly enlarged. The pericardium adjacent to the right atrium was infiltrated
in 10 cases. Two invaded the tricuspid valve and extended into the right ventricle, and two protruded
into the superior or inferior vena cava. Metastases occurred in eight patients, with the lungs being the
most frequently involved organ (8/12 patients, with pleural effusion in three patients), followed by
the remote pericardium (3/12 patients), mediastinal lymph nodes (2/12 patients), brain (1/12 patients),
kidney (1/12 patients), and spleen (1/12 patients; Figure 1). Eleven patients developed pericardial
effusion, and three evolved to cardiac tamponade. The maximum size of lesions varied from 38.4 to
93.0 (range: 64.8 ± 16.6) mm.
Figure 1. Male, 52 years old, right atrium angiosarcoma. (a–c): Contrast-enhanced computed
tomography (CT) scans in the arterial (a) and venous (b) phase indicates a mass with heterogeneous
centripetal enhancement (red arrow), and multiple solid nodules (c) are noticed in the lungs
(yellow arrow). (d–g): 1.5 months later, pericardial effusion appears (d), metastases (yellow arrow) in
the lungs are more extensive, halo sign appears (e, orange arrow). Metastasis in the right side of the
cerebellum (blue arrow) presents as inhomogeneous hyperintensity on T1WI (f) and hypo-intensity
on T2WI (g) with surrounding edema. (h–l): Another month later, the mass (red arrow) becomes
larger, and the adjacent pericardium invasion is more extensive (h), and metastases in the lungs are
much more extensive (i). The metastasis in the right side of the cerebellum (blue arrow) is larger (j).
Metastases in the kidney (k, green arrow) and spleen (l, purple arrow) appear.
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3.3. CT Findings
The detailed CT features of each patient are listed in Table 2. On unenhanced CT scans, lesions
in two patients manifested only as an enlarged right atrium, and the other six patients showed
inhomogeneous density with low-density areas. On contrast-enhanced CT scans, 10 lesions were
heterogeneously enhanced in the arterial phase, and four of them showed strong enhancement.
The right coronary artery (RCA) was enwrapped by the tumor in seven patients, and one of them
showed small tortuous vessels deriving from the RCA to supply the neoplasm (Figure 2); in the delayed
phase, the enhancement scope was broadened. Low-density areas showed no enhancement.
Figure 2. Male, 34 years old, right atrium angiosarcoma. (a–c): The mass (red arrow) is heterogeneously
enhanced in the arterial (a) and venous (c) phase of contrast-enhanced CT images, and small tortuous
vessels (b, red arrow) deriving from the right coronary artery (RCA) and pericardial effusion are
noticed. (d,e): The mass (red arrow) presents as heterogeneous intensity, with multiple hyperintense
hemorrhage foci on T1WI (d) and T2WI (e). (f–h): late-phase gadolinium enhancement (LGE) shows
heterogeneous rim enhancement (red arrow) on four-chamber (f), two-chamber (g), and short axis
(h) planes. Pericardium enhancement is noticed in the short axis plane (yellow arrow).
Upon initial diagnosis, metastatic nodules in the lungs were observed in seven patients.
The nodules were surrounded by ground-glass opacity (halo sign) in five of the seven patients,
and two of them also showed diffuse smooth thickening interlobular septa in both the lower lobes of
the lungs. Another patient showed multiple string-of-beads effusion in the interlobular fissures of
both lungs. The enhancement pattern of metastases in the remote pericardium, mediastinal lymph
Diagnostics 2020, 10, 776 6 of 12
nodes, kidney, and spleen was the same as that of the primary lesion. Brain metastases in two patients
presented as high-density areas on unenhanced CT scans.
Table 2. CT features of primary cardiac angiosarcoma.
Case Scan Type Density Enhancement Pattern Differentiation(Ki-67 Index)
Lung
Metastasis
GGO
Peripheries
1 E - Heterogeneous Moderate (>50%) N -
2 P + E Uneven StrongHeterogeneous Centripetal Low (80%) Y N
3 P Uneven - Low (85%) N -
4 E - HeterogeneousCentripetal Moderate (30%) N -
5 P + E Uneven Moderate HeterogeneousCentripetal Low (30%) N -
6 E - Heterogeneous Centripetal Moderate (25%+) Y N
7 P Uneven - High (10%+) Y N
8 P + E Even
Strong
Heterogeneous
Centripetal
NK (30%) Y Y
9 P + E Uneven
Strong
Heterogeneous
Centripetal
NK (50%+) Y Y
10 P + E Even
Mild
Heterogeneous
Centripetal
High (50%+) Y * Y
11 P + E Uneven StrongHeterogeneous NK (50%+) Y * Y
12 E - HeterogeneousCentripetal NK (20–25%+) Y Y
Abbreviations: GGO-ground-glass opacity, P-CT plain scan; E-CT enhanced scan; NK-Not Known; Y-Yes; N-No
* Diffuse smooth thickening interlobular septa in both lower lobes of lungs.
3.4. MRI Findings
The detailed MRI features of each patient are listed in Table 3. Two lesions were irregular
in shape, and two were approximately round. All the four lesions manifested as heterogeneous
intensity, with hyperintense hemorrhage foci on both T1- and T2-weighted images compared with the
myocardium. Signal void was noticed within one lesion. Cine MRI sequences showed that masses
were fixed on the wall of the right atrium with a broad base and did not move with the heart; the
motion of the right atrium and ventricle was impaired. First-pass perfusion sequences demonstrated a
filling defect in the right atrium as the contrast medium transited the right side and enhanced masses as
it went through the left side (Figure 3). Four lesions were all heterogeneously enhanced in the delayed
phase, one lesion showed patchy enhancement, and the other three lesions showed rim enhancement.
Pericardium enhancement was noted in one patient.
Table 3. Magnetic resonance imaging (MRI) features of primary cardiac angiosarcoma.
Case Boundary Intensity onT1WI
Intensity on
T2WI
Signal
Void Enhancement Pattern Differentiation
Pericardium
Enhancement
2 Regular Uneven high Uneven high Y Heterogeneous, patchy Low N
4 Regular Uneven high Uneven high N Heterogeneous, rim Moderate Y
7 Irregular Uneven high Uneven high N Heterogeneous, rim High N
11 Irregular Uneven high Uneven high N Heterogeneous, rim NK N
Abbreviations: NK-Not Known; Y-Yes; N-No.
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Figure 3. Male, 74 years old, right atrium angiosarcoma. (a–c): The mass (red arrow) in the right
atrium presents as inhomogeneous density with low-density areas on plain CT scans (a) and shows
strong heterogeneous centripetal enhancement on enhanced CT scans (b,c), and the low density area
(pink star) shows no enhancement. (d–f): Signal void (red arrow) is noticed on a black-blood haste
sequence (d). The mass (red arrow) presents as heterogeneous hyperintensity on T1WI (e) and T2WI (f).
(g–h): On first-pass perfusion sequences, the mass (red arrow) presents as a filling defect in the right
atrium as the contrast medium transits the right side (g) and is enhanced as the medium goes through
the left side (h). (i–k): LGE shows heterogeneous patchy enhancement (red arrow) on different planes.
3.5. PET/CT Findings
Four patients underwent PET/CT examination, and their lesions were observed to be
hypermetabolic with increased glucose uptake. Solid pulmonary nodules were noticed in three
patients, and abnormal masses were found in the pericardium in one patient with intensive glucose
uptake, which confirmed their metastatic property.
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3.6. Pathological Results
Primary tumor specimens were collected through radical resection (six patients) and thoracotomy
biopsy (two patients). Macroscopically, tumors were incanous or taupe in color, with a taupe solid
section (some with cystic degeneration), and generally soft in texture. Four patients underwent
transthoracic needle biopsy of pulmonary nodules; the biopsy findings confirmed metastases from
primary cardiac angiosarcoma in the specimens, presenting as pinkish-grey or dark red. Tumor cells
were aligned in a spindle or solid manner, and vascular cavity-like structures were observed in all
patients. The differentiation degree of lesions was analyzed among eight patients within our hospital
but was not available for the remaining four from other institutions. Immunoreactivity for CD31 and
CD34 was most diffuse in all cases, followed by Ki-67, Vimentin and smooth-muscle actin (SMA). The
differentiation degree of lesions and Ki-67 index are listed in Table 2.
4. Discussion
To the best of our knowledge, this is the largest cohort study of primary cardiac angiosarcoma
that performed a multimodality analysis of imaging features. Angiosarcoma is a rare entity, and its
etiology is still not fully understood. Definite risk factors include chronic lymphoedema, radiation
exposure, and a history of exposure to environmental carcinogens [12]. Several familial reports of
cardiac angiosarcoma have indicated its genetic association [13,14]. In our study, the clinical features
of all patients and the site and size of all lesions are in correspondence with prior reports.
No studies have thus far reported the role of carcinoembryonic antigens in the pathogenesis
of primary cardiac angiosarcoma. CA-125 is a product of the normal endometrium and decidua
and is present in the normal ovarian epithelia and epithelia of the colon, lung, pancreas, kidney,
and gall bladder; CA-125 is a marker of coelomic epithelial stimulation [15]. Histologically, cardiac
angiosarcomas consist of endothelium-lined channels and vascular channels mixed with solid areas of
epithelioid and spindle cells, which can be divided into the following three types according to the
amount of these three components: a vascular area with anatomizing channels, a solid high-grade
epithelioid area, and a spindle cell Kaposi-like area [6]. Because three patients in our study with an
increased serum CA-125 level did not have additional diseases, we suppose that serum CA-125 level
increases when the epithelioid cells of tumors reach a certain proportion. Thus, serum CA-125 may
be a helpful biomarker to monitor cardiac angiosarcoma when other relevant diseases are excluded,
especially for men.
Standard treatment is yet to be determined owing to the rarity of this particular disease. Surgical
resection is the conventional and preferable choice when possible, and the exact benefits of radiotherapy
and chemotherapy remain controversial [6]. In our study, PET/CT was re-performed eight months
after chemotherapy with paclitaxel for one patient, which revealed an obvious decrease in tumor size,
indicating the effectiveness of chemotherapy for some patients in the late period.
Transthoracic echocardiography is the first-line modality used to identify cardiac masses, but it is
dependent on the operator and acoustic windows [16]. In our study, transthoracic echocardiography
could not show the lesion even when performed by different operators because of a large amount of
pericardial effusion in one patient. Thus, CT and MRI are necessary for further differential diagnosis.
CT is more efficient at tissue characterization and can monitor systemic metastases, especially in
the lungs [6,12]. Primary cardiac angiosarcoma often presents as homogeneous or inhomogeneous
density on unenhanced CT scans and heterogeneous centripetal enhancement on enhanced images.
Yu et al. argued that this phenomenon can be attributed to the lack of vascularity in the mesenchyma
of angiosarcoma and abundant vascularity in the parenchyma [8], but they did not discuss this in
detail. Microscopically, the mesenchyma of angiosarcoma are composed of epithelial and spindle cells,
whereas the parenchyma consists of endothelium-lined vascular channels [6]. In a study of hepatic
angiosarcoma reported by Yi et al. [17], highly differentiated hepatic angiosarcoma exhibited annular
enhancement in the arterial phase, no internal enhancement, and continuous centripetal filling during
the venous and delay phases; however, for poorly differentiated tumors, the enhancement was not
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obvious or was heterogeneous for all scan phases. In our study, the differentiation degree analysis of
lesions with both unenhanced and enhanced-contrast CT scans was only available in three patients.
Surprisingly, two lesions with low differentiation showed strong or moderate enhancement in the
arterial phase, while the one with high differentiation exhibited mild enhancement in the arterial phase.
The Ki-67 index too does not correlate with the differentiation degree of the tumors. This phenomenon
may be ascribed to the different proportion of parenchyma in the lesion, and it indicates that the
enhancement pattern of tumors on CT scan is not reliable for prediction of the degree of malignancy of
primary cardiac angiosarcoma. Studies with large samples are needed to clarify the reason for the
inconsistency of this phenomenon between primary hepatic and cardiac angiosarcoma. Low-density
areas within lesions showed no enhancement, which may represent hemorrhage or necrosis within the
tumor. CT imaging can also provide insights into detailed peripheral infiltration, including pericardial
thickening and effusion, the scope of tumor invasion, and the relationship between the lesion and
RCA [18]. Small vessels in the mass deriving from the RCA demonstrated that the blood supply of the
tumor was from the RCA [9,19].
CT has its limitations. Its histological resolution is poorer than that of MRI. In two patients, only a
slightly enlarged right atrium was observed on unenhanced CT scans, which may be neglected by
unexperienced doctors. Furthermore, because a contrast agent is usually injected through the right
cubital vein, the blood flow artifact in the right atrium can affect the observation of the lesion.
Cardiac MRI has a high temporal and spatial resolution and provides great noninvasive tissue
characterization without radiation exposure. It is helpful for heart function evaluation, surgical
preparation, and postoperative follow-up. Consequently, cardiac MRI is recommended as the standard
technique for the assessment of cardiac tumors [20]. In our study, the lesions of four patients who
underwent MRI examination all showed heterogeneous intensity, with hyperintense hemorrhage
foci (known as cauliflower-like appearance) on both T1- and T2-weighted images compared with the
myocardium, whereas their corresponding unenhanced CT scans showed no sign of hemorrhage,
which is in line with the findings of previous studies [21,22]. The lesion of case 4 (Figure 2) presented
as irregular pattern on CT scan but was almost round with clear boundary on MRI images. Other MRI
features suggesting cardiac malignancies, such as origin from the right heart chamber, broad based
attachment, involvement of >1 chamber, size > 5 cm, and ill-defined margins [21], were noticed in the
majority or all patients. Signal void was noticed in one lesion with strong enhancement in the arterial
phase on CT scan.
“Sunray appearance” was first observed by Yahata et al. in 1994 [23]. The second relevant report
was published by Tüdös et al. in 2017 who discovered that hyperintense lines were enhanced bands of
the fibrous tissue, whereas hypointense regions were based on unenhanced hematoma and necrosis [24].
Thereafter, “sunray appearance” was regarded as a typical LGE pattern by many [25]. However,
Tüdös et al. questioned this argument and indicated that peripheral rim enhancement with central
necrosis or hemorrhage may be more typical [26] because another study reported that the enhancing
rim was a reliable feature to distinguish cardiac angiosarcoma from cardiac lymphoma [27]. In our
study, “sunray appearance” enhancement was absent, and rim enhancement was the common pattern.
Additional studies with large samples are needed to determine the typical contrast-enhancement
pattern of primary cardiac angiosarcoma on MRI images.
Comparison among studies of imaging features (including CT and MRI) of primary cardiac
angiosarcoma and our study is exhibited in Table 4. Our study adds more information in terms of
both cardiac CT and MRI imaging features of primary cardiac angiosarcoma when compared to these
studies, of which most are isolated case reports.
Diagnostics 2020, 10, 776 10 of 12
Table 4. Comparison among studies on imaging features of primary cardiac angiosarcoma.
Study Number of Patients CT Features MRI Features
Antonuzzo et al. [4] 1 None A mass (53 mm) extending from the free wall of the RA to the anterior mediastinum
Yu et al. [8] 9
Masses in the RA invading pericardium, RV, SVC, and tricuspid valve,
presented as homogeneous or inhomogeneous on plain CT scans, and
most showed inhomogeneous centripetal enhancement on enhanced CT
scans. Pulmonary metastases with GGO peripheries
None
Rao et al. [9] 1 A mass in the RA and RV extending into the pericardium A large heterogeneous mass in the RA and RV extending into the myocardium.
Yahata et al. [23] 1 None An extensive mass in pericardial cavity protruding into the RA of heterogeneous signalintensity on T1WI and T2WI, “sunray appearance” enhancement was seen on LGE images.
Tüdös et al. [24] 1 None
A cauliflower mass protruding to the RA with extension toward RV, right appendage, and
diffuse obliteration of pericardial cavity around the ventricles, RV motion was severely
impaired. Signaling of tumor tissue in T1WI and T2WI was inhomogeneous, mostly
isointense to slightly hyperintense. Pattern of enhancement previously described as
“sunray appearance” was seen both on T1WI and LGE images, especially LGE images.
Lindsey et al. [25] 1 None
A well-circumscribed, hyperemic mass (27 × 18 mm) located at the supero-posterior wall of
the RA and possibly extending from the IVC, presented as hyperintensity on T2WI and
LGE. Using first-pass
perfusion, the mass did not show contrast as it transited the right side, but, as contrast
passed through the coronary arteries, the contrast filled the mass.
Colin et al. [27] 7 None
Tumors located in the right atrial wall and
atrial appendage extending to the pericardium, right atrial cavity, and right coronary artery
with central necrosis and possibly pulmonary metastasis, and with strong rim
enhancement on LGE.
Sun et al. [28] 1
A large mass about 8 × 6 × 5 cm3 occupying the RA, SVC and IVC with
pericardial and bilateral pleural effusion, with heterogeneous
enhancement.
None
Park et al. [29] 1 Multiple-septated fluid collection in right pericardial space. Diffuse nodular enhancing mass involving the right atrium.
Qian et al. [30] 1
A multifocal high-density shadow and lymph node enlargement
(including the right upper lobe) with bilateral pleural effusions, a
pericardial effusion and an enlargement of the cardiac area. Pulmonary
artery computed tomography angiography (CTA) demonstrated a
micro-embolism in the right upper lobe of the lung.
None
Our study 12
Masses in the right atrium invading pericardium, RCA, RV, SVC and IVC,
presented as homogeneous or inhomogeneous on unenhanced CT scans
and heterogeneous centripetal enhancement on enhanced CT scans, The
enhancement pattern shows no exact correlation with the differentiation
degree of the tumor. Pulmonary metastases with halo sign was common.
Masses in the right atrium invading pericardium, RCA, RV, SVC and IVC, presented as
cauliflower-like appearance on T1WI and T2WI, signal void was noticed in a lesion with
strong enhancement for arterial phase on CT scan. RA and RV motion was severely
impaired. Rim enhancement was noticed in 3 patients and patchy enhancement was
noticed in one patient.
Abbreviations: RA-right atrium; RV-right ventricle; SVC-superior vena cava; IVC-inferior vena cava; RCA-right coronary artery, LGE-Late gadolinium enhancement,
GGO-ground-glass opacity.
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5. Conclusions
Primary cardiac angiosarcoma is rare, and its prognosis is extremely poor. The right atrium
is the most common involved site, whereas peripheral invasion, including the pericardium, right
coronary artery, tricuspid valve, and right ventricle, was universal. CT features included typical
inhomogeneous density on unenhanced scans and heterogeneous centripetal enhancement on enhanced
scans. The enhancement pattern shows no exact correlation with the differentiation degree of the tumor.
Multiple intrapulmonary solid nodules with halo sign may support the diagnosis. Cauliflower-like
appearance on both T1- and T2-weighted MRI is common. The characteristic enhancement pattern of
MRI remains to be determined, whereas rim enhancement as a supportive pattern may be considered
a diagnostic marker. Familiarity with these imaging characteristics associated with primary cardiac
angiosarcoma may assist accurate diagnosis and improve patient prognosis.
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